Simple blood test may spot newborns at risk for lung trouble
NCT ID NCT07394322
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether measuring a substance called interleukin-6 (IL-6) in the blood can predict which newborns will develop meconium aspiration syndrome, a serious breathing problem. Researchers tested 120 full-term infants born with meconium-stained amniotic fluid. The goal was to see if IL-6 levels could serve as an early warning sign.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
serum interleukin-6 test
What this could lead to
If successful, this could help doctors identify newborns at risk for meconium aspiration syndrome early, allowing for quicker monitoring and care.
What could go wrong
This is a small, completed diagnostic study, not a treatment trial. The test may not be accurate enough for routine use, and results need confirmation in larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MECONIUM ASPIRATION SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Benha Faculty of Medicine
Banhā, 15312, Egypt